Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  42.00 3.39% 1,282.00 1,272.00 1,284.00 1,284.00 1,230.00 1,230.00 160,884 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.3 0.7 1.0 1,282.0 506

Biotech Growth Share Discussion Threads

Showing 226 to 247 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
21/8/2015
07:05
BIOG was outperforming over the usual 1 yr and 5 yr yardsticks but has underperformed in a similar fashion recently. As was indicated by urgentclick it's a question of committing oneself when sentiment in the far east and emerging markets quieten down. I'm waiting a bit longer for this to happen and then, hopefully, to see the turn before I further invest.
iomhere
20/8/2015
15:55
Bought some more today to accumulate for when global sentiment improves.
urgentclick
20/8/2015
15:15
The net asset value seems to be dropping though ? Interested here but surely if NAV dropping its a reason to wait and see? Opinions welcome.
hazl
19/8/2015
15:51
Usually very little or no discount to NAV. They, the company, usually buy back their own shares when it exceeds 8% from memory. I also think, unlike Tech funds, that China is not a factor. I have bought BIOG IMT and Allianz Insurance today.
philo124
19/8/2015
15:04
Hi Philo- do you mean the discount has widened- please expand why you think this is an opportunity to add?
ali47fish
19/8/2015
11:48
Bought this am. The opening 10% discount is very rare.
philo124
27/7/2015
15:44
As ever following Nasdaq Bio Index which had a large drop Friday.
dragonsteeth
27/7/2015
15:32
Back in today for my Biotech jab. But -6%! Yet looks like price alignment with the uptrend line.
urgentclick
11/6/2015
15:04
Good luck getting back in if that's what you do. I went in heavy for Woodford and then lost my bottle and cut back my application just prior. Damn!!
jl9
11/6/2015
12:44
Yeah, problem! I shall instead extend my existing hose I think, London housing has gone absolutely nuts. I mean crazy stupid mute, so much cash sloshing round underpinned by cheap borrowing rates. You just know that it'll end in tears for some. But when?..... House next door up for sale, was in garden when it was being shown and I swear that not one single solitary person who looked at it was native British, all foreign accents. And I don't live in the posh bit, zone 5, terrace house. Anyway, cash is king but earns nothing. Tempted by woodwards patient capital. Not dissimilar to this but wider industries. Will look to get back here at the right price. Am in Japan and Europe via funds as well, both have significant upside short/medium term. Just try to pick European funds with low Financials exposure just in case Grexit, Cos they'll get hit hardest. My view is that most Decent European companies will probably wobble on Grexit, but are cheap and will bounce back. Let's be honest, who gives a damn what happens to Greece, small market, no major companies I hold. Just a bit messy from liquidity perspective, good buying opportunity for me, hold what I have and buy Quality divi payers on the dip. Shell, BAE, Nestle, unilever, siemens etc I almost want that to happen!
affemoose
11/6/2015
11:58
AffeMoose Now you're stuck in cash and don't know what to do. Familiar problem. I'm sticking with my biotech exposure as it seems to offer the most secure growth in the years ahead.
jl9
11/6/2015
11:50
Ooops, meant the post the below in case you do not know already. Sorry about above rant!! Geoffrey Hsu of OrbiMed Capital LLC, the Portfolio Manager of The Biotech Growth Trust PLC, will be presenting to investors and shareholders in London on Wednesday, 8 July 2015. BIOG has performed exceptionally well over a sustained period, significantly outperforming both the FTSE All-Share benchmark and the NASDAQ Biotechnology Index over 1, 3 and 5 years. OrbiMed is the world's largest specialist healthcare fund manager with over $15bn invested worldwide. Geoffrey Hsu will provide an update on the biotech sector and the factors determining future growth. The presentation will start soon after 12.15pm, immediately after the conclusion of the ordinary business of the AGM, which commences at 12 noon. More information on The Biotech Growth Trust PLC can be found at www.biotechgt.com. Details are as follows: BIOG AGM and Investor Presentation: Date: Wednesday 8th July Time: 12 noon – AGM 12:15 – Investor Presentation 13:30 – Buffet Lunch Venue: Barber Surgeons' Hall, Monkwell Square, London EC2Y 5BD Please RSVP to info@frostrow.com if you are able to join us, as places are limited.
affemoose
02/6/2015
14:24
Creeping up.
philo124
29/4/2015
14:38
probably, but i find it best to have money to grip with!! be back when I have some - all sitting in lawyers, Estate Agents and HMRC's pockets at the moment.
affemoose
29/4/2015
14:17
Thanks. I agree this is an exciting area for growth. But you can only capture it with certainty by gritting your teeth and holding on through the ups and downs.
jl9
29/4/2015
13:49
2 fold - yes to personalised, but also targeted as in targeting a specific disease. Most cancers are, I believe, not 1 cancer but different ones targeting the same body areas. so for instance there is more than 1 lung cancer, prostate cancer etc. Up to now drugs are just for 'prostate' - but they are moving towards hitting each cancer in its own right, which will then lead to personalised longer term. Anyway - that's my ramblings.
affemoose
29/4/2015
12:38
AffeMoose - by 'targeted drugs' do you mean personalised medicine?
jl9
29/4/2015
10:14
Well - I got out of here a few short weeks back as I needed the cash for a house. But I do like BIOG and have kept a close eye on things since and what a rollercoaster ride you have all had!! I sold at something like 798. Since then i dropped, roared above to mid 800's, slumped back to mid 700's etc etc I have gone from patting myself on the back to kicking myself to being glad I sold when i did. I have absolutely no idea whatsoever where the next few months will take this - my guess is targeted at 720, if it breaks through this then 675. My uninformed guess is that this share will move, in a very volatile way, sideways for a while. Spiking and crashing it's way across the chart for a while. BUT - longer term I cannot see this sector going anywhere except upwards. We are just at the start of this journey into Targeted drugs. SO - selfishly - I hope for the 600's to be revisited so when i do have some cash, I can get in at a decent price again. But GLA in your holdings.
affemoose
28/4/2015
11:02
Have a look at the forward p/e ratios of the constituents of the DJIA- they are not stretched imo. In a deflationary environment what are the sectors that have growth and pricing power? I can only think of 2.
philo124
28/4/2015
10:53
This is on my buy list, I just cannot bring myself to buy at this price. I cannot believe that we'll get through the summer without the market having a wobble, and when it does, there are half a dozen trusts on a discount that will become bargains. Of course, it may not happen and I may miss out.
mad foetus
28/4/2015
10:49
They have a mandate to buy back when discount is greater than 8%. Whether it's 760p or 660p, the price will be 1200p+ in 5 years time.
philo124
28/4/2015
10:45
Thanks. So it seems we can expect a significant drop in next NAV.
redhill9
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200808 12:56:41